Bio Green Med Solution, Inc. (BGMSP) EPS (Basic) (2010 - 2026)
Bio Green Med Solution (BGMSP) posted quarterly EPS (Basic) of -$0.04 for Q1 2026, up 82.07% year-over-year from -$0.02 in Q1 2025, and up 99.15% quarter-over-quarter from -$4.65 in Q4 2025.
Bio Green Med Solution, Inc. (BGMSP) EPS (Basic) (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMSP) has reported EPS (Basic) for 17 consecutive years, with -$0.04 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) rose 82.07% year-over-year to -$0.04; the TTM figure through Mar 2026 stood at -$2.61 (up 88.59% YoY), while the FY2025 annual figure was -$6.45, up 98.72% from the prior year.
- EPS (Basic) grew to -$0.04 in Q1 2026 per BGMSP's latest filing, from -$4.65 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.04 in Q1 2026 and bottomed at -$2388.6 in Q4 2022.
- Historically, EPS (Basic) has averaged -$868.65 across 5 years, with a median of -$852.43 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 717.69% — and 2025, when it jumped 99.97%.
- Bio Green Med Solution's EPS (Basic) stood at -$2388.6 in 2022, then soared by 37.32% to -$1497.2 in 2023, then jumped by 90.86% to -$136.78 in 2024, then soared by 96.6% to -$4.65 in 2025, then jumped by 99.15% to -$0.04 in 2026.
- Business Quant data shows BGMSP's EPS (Basic) at -$0.04 in Q1 2026, -$4.65 in Q4 2025, and -$1.31 in Q3 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -4.65 |
| Sep 30, 2025 | -1.31 |
| Jun 30, 2025 | -0.51 |
| Mar 31, 2025 | -0.22 |
| Dec 31, 2024 | -136.78 |
| Sep 30, 2024 | -43.80 |
| Jun 30, 2024 | -70.77 |
| Mar 31, 2024 | -852.43 |
| Dec 31, 2023 | -1,497.19 |
| Sep 30, 2023 | -1,839.13 |
| Jun 30, 2023 | -1,576.71 |
| Mar 31, 2023 | -1,680.73 |
| Dec 31, 2022 | -2,388.55 |
| Sep 30, 2022 | -1,534.05 |
| Jun 30, 2022 | -1,642.40 |
| Mar 31, 2022 | -1,497.84 |
| Dec 31, 2021 | 386.69 |
| Sep 30, 2021 | -2,565.33 |
| Jun 30, 2021 | -2,018.32 |